AU2462097A - The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain - Google Patents

The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain

Info

Publication number
AU2462097A
AU2462097A AU24620/97A AU2462097A AU2462097A AU 2462097 A AU2462097 A AU 2462097A AU 24620/97 A AU24620/97 A AU 24620/97A AU 2462097 A AU2462097 A AU 2462097A AU 2462097 A AU2462097 A AU 2462097A
Authority
AU
Australia
Prior art keywords
antagonist
medicament
substance
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24620/97A
Inventor
Daniel A. Gamache
John M. Yanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU2462097A publication Critical patent/AU2462097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
AU24620/97A 1996-10-04 1997-04-17 The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain Abandoned AU2462097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72689096A 1996-10-04 1996-10-04
US08726890 1996-10-04
PCT/US1997/006410 WO1998014193A1 (en) 1996-10-04 1997-04-17 The use of a substance p antagonist for the manufacture of a medicament for the treatment of ocular pain

Publications (1)

Publication Number Publication Date
AU2462097A true AU2462097A (en) 1998-04-24

Family

ID=24920455

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24620/97A Abandoned AU2462097A (en) 1996-10-04 1997-04-17 The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain

Country Status (2)

Country Link
AU (1) AU2462097A (en)
WO (1) WO1998014193A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142810A0 (en) * 2000-05-03 2002-03-10 Pfizer Prod Inc Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
TW200927192A (en) * 2007-11-19 2009-07-01 Alcon Res Ltd Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
CA3091944A1 (en) 2018-02-26 2019-08-29 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
WO2020243496A1 (en) * 2019-05-30 2020-12-03 The Schepens Eye Research Institute, Inc. A therapeutic approach for treating non-infectious ocular immunoinflammatory disorders
US20230134843A1 (en) 2020-03-11 2023-05-04 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742156A (en) * 1985-09-30 1988-05-03 Mcneilab, Inc. Peptide antagonists of neurokinin B and opthalmic solutions containing them
UA41251C2 (en) * 1990-01-04 2001-09-17 Пфайзер, Інк. Hydrogenated nitrogen-containing heterocyclic substances, piperidine derivatives, pharmaceutical composition and method for inhibiting activity of p substance
WO1996014845A1 (en) * 1994-11-10 1996-05-23 Pfizer Inc. Nk-1 receptor antagonists for the treatment of eye disorders

Also Published As

Publication number Publication date
WO1998014193A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
AU6667698A (en) Battery-powered patient implantable device
AU4342997A (en) Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
AU5588896A (en) Implantable medical device
ZA966319B (en) Corneal irrigation cannula
AU3886199A (en) Medical device for dissolution of tissue within the human body
AU2039800A (en) 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
AU2844299A (en) Safety syringe for medical use
AU2935597A (en) Therapeutic treatment for vegf related diseases
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU8869398A (en) Medical apparatus for relief of pain
AU3968695A (en) Patient operated tonometers
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
AU7982098A (en) Use of beta2-adrenoceptor agonists for the manufacture of a medicament for the treatment of scoliosis
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
AU4179497A (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment f AIDS
AU2566201A (en) Compounds and methods for the treatment of pain
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
EP0878200A4 (en) Therapeutic agent for ophthalmic diseases
IL135171A0 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
AU3190595A (en) Corneal therapeutic agent
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8